All Type of News
Generics of Albis, which are more expensive than the original… competing with 10 different products
It is expected that generics of the antiulcer drug ‘Albis’ will be launched in earnest on this November. About 10 products will receive their price and be opened in the market next month.
Albis is a drug that recorde...
Ministry of Food and Drug Safety turned in the final draft of Patent Linkage System to the National Assembly
The final draft of Patent Linkage System that sets basis of drug sales restriction has been confirmed, and submitted to the National Assembly.
In order to enforce the Patent Linkage System followed by the Korea-US FT...
Possibility of economical saving through generic substitution with less expecsive products for more than KRW 300 billion
It was suggested that over KRW 300 billion of the health insurance budget can be saved if generic substitution for same component drugs is activated.
Congressman Dong-ik Choi in the Health and Welfare Committee of th...
KRW 50 billion worth of the Nexium market… having conflicts with improved new generics
The Nexium (Esomeprazole) Market reaching collective KRW 35 billion for the third quarter of the year is like the calm before the storm.
Despite the aggressive sales marketing of improved new drugs, Nexium, the origi...
Pfizer loaded with three creative and improved pharmaceutical products
It is having the similar effect with existing products as well as better merits.
They are the similarities of pipelines that Pfizer added in the Korean market, recently.
Products related are an antidepressant drug ‘...
Comparison of 8 Japanese pharmaceutical companies on the third quarter of the year
It was shown that among Japanese pharmaceutical companies branched in Korea had different sales records on the third quarter of the year.
They seem ‘pretty good’ overall in the amount of prescriptions; although 5 com...
The pharmaceutical distribution companies stating “No exception for Japanese pharmaceutical companies”
It was known that some Japanese pharmaceutical companies branched in Korea are providing lower distribution cost than the break-even point for wholesales companies.
Accordingly, the pharmaceutical distribution indust...
Innovation pharmaceutical companies has received huge benefits through corporate tax reductionSince innovation pharmaceutical companies were chosen, the government has supported the companies more than what people has expected for the last 3 years.
It was not as enough ...
|
Necessity of online pharmacies?... Uncommon movements of the business world
As the Korea Chamber of Commerce and Industry (hereinafter referring to KCCI) begun to argue on allowing online sales of safety household medicines, the industry is expected to be noisy. In other words, it is asking f...
‘Two different results’ of Xtandi vs Zytiga
New drugs for late state prostate cancer had two different results.
While Astellas Pharmaceutical’s ‘Xtandi Capsule(Enzalutamide)’ is registered on the positive list, Janssen’s ‘Zytiga Tab(Abiraterone Acetate)’ could...
